Update on pharmacotherapies for cholestatic liver disease

Cholestatic liver diseases are conditions with impaired bile formation and/or flow due to genetic, immunologic, environmental, or other causes. Unless successfully treated, this can lead to chronic liver injury and end‐stage liver disease. Primary biliary cholangitis (PBC) and primary sclerosing cho...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Ahmad H., Tabibian, James H., Lindor, Keith D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747033/
https://www.ncbi.nlm.nih.gov/pubmed/29404429
http://dx.doi.org/10.1002/hep4.1013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747033/
https://www.ncbi.nlm.nih.gov/pubmed/29404429
http://dx.doi.org/10.1002/hep4.1013

Ejemplares similares